pharma · MPS IIIA · Epidermolysis Bullosa · ABEO
ABEONA THERAPEUTICS
ABEONA THERAPEUTICS INC.
ABEONA THERAPEUTICS trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.
Cleveland, USA HQ
2015 Founded
228 Employees
Public company Type
ABEO · NYSE Ticker
Company details
- Status
- Public
- HQ
- Cleveland, USA
- Founded
- 2015
- Employees
- 228
- Programs
- 8
- Drugs
- 3
- Patents
- 0
ABEONA THERAPEUTICS clinical trials
Registry index of 9 ClinicalTrials.gov studies linked to ABEONA THERAPEUTICS programs — each row shows trial ID, program name, phase, status, and indication.
ABEONA THERAPEUTICS trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for ABEONA THERAPEUTICS.
-
LZRSE-Col7A1 Engineered Autologous Epidermal Sheets — Phase 2
Clinical update -
EB-101 — Phase 3
Clinical update -
EB-101 Surgical application of RDEB wounds — Phase 3
Clinical update -
UX111 — Phase 3
Clinical update -
ofloxacin — Phase 3
Clinical update -
ABO-102 — Phase 2
Clinical update -
EcoNail™ (econazole 5%/SEPA® 18% nail lacquer) — Phase 2
Clinical update -
rAAV9.CMV.hNAGLU — Phase 2
Clinical update